Pharmacology of the Renal System: Diuretics

I. Introduction: The Kidneys and the Nephron

Pharmacology can seem intimidating, but it becomes beautiful once you understand the underlying physiology. Before we memorize drugs, we must understand the organ they target: The Kidneys.

The functional unit of the kidney is the Nephron. Its job is to filter the blood and form a protein-free plasma filtrate (Ultrafiltration). The nephron is a tubular structure consisting of specific segments, each with unique transport mechanisms:

1. Renal Corpuscle (Glomerulus + Bowman's Capsule): Where filtration begins.
2. Proximal Convoluted Tubule (PCT): The heavy worker, reabsorbing the bulk of water and solutes.
3. Loop of Henle (Descending and Ascending limbs): Creates the concentration gradient.
4. Distal Convoluted Tubule (DCT): Fine-tunes the filtrate.
5. Collecting Duct: The final arbiter of water and potassium balance.

---

II. Clinical Case Study: The Presentation of Fluid Overload

Let us anchor our pharmacological knowledge to a real patient presentation.

---

III. Diuretics: General Principles & Cardiovascular Effects

Diuretics are crucial for the management of Cardiovascular (CVS) diseases. By definition, diuretics are drugs that block renal ionic transport (specifically the reabsorption of Na⁺ and Cl^-). This blockade causes diuresis (an increase in urine volume), which is almost always associated with natriuresis (an increase in Na⁺ excretion).

• The 1% Rule: The increase in urine flow is directly related to the amount of Na⁺/Cl^- reabsorption blocked. If a drug blocks just 1% of normal solute reabsorption, urine output will increase by a massive 1.8 Liters per day!

How Diuretics Help the Heart (CVS Effects)

You might wonder, why do we use kidney drugs for heart problems? Here is the physiological chain reaction:

1. Diuretics decrease Na⁺ and water balance, leading to a decrease in total blood volume and venous pressure.
2. This directly decreases the preload (the volume of blood filling the heart), which drops ventricular stroke volume and cardiac output, safely lowering arterial blood pressure.
3. The decrease in venous pressure reduces capillary hydrostatic pressure. This stops fluid from leaking out of the vessels and promotes fluid reabsorption back into the blood, effectively reducing edema (swelling).
4. Long-term Effect: Prolonged use of diuretics results in a fall in systemic vascular resistance (by mechanisms still somewhat unknown), which helps sustain long-term reductions in blood pressure.

Mechanisms of Action

Diuretics force the body to lose water through four main pathways:

---

IV. Loop Diuretics (High-Ceiling Diuretics)

Examples: Furosemide (Lasix - Prototype), Bumetanide, Torsemide, Ethacrynic acid.

These are the most powerful and effective diuretics available. They produce a greater loss of fluids and electrolytes than any other class.

• Site of Action: They act specifically on the Thick Ascending Limb (TAL) of Henle's loop.
• Mechanism of Action: They directly block the Na⁺/K⁺/2Cl^- co-transporter on the luminal membrane. Normally, this massive pump reabsorbs 25% of all filtered NaCl. By blocking it, a massive amount of sodium (and therefore water) stays in the urine. They also induce the renal synthesis of prostaglandins, which vasodilates renal blood vessels.

1. Pharmacokinetics

• Oral Administration: Diuresis begins in 60 minutes and persists for about 8 hours.
• Intravenous (IV) Admin: Diuresis begins in 2 minutes and persists for 2 hours (perfect for the emergency room).
• Undergoes hepatic metabolism and active renal excretion (secreted into the proximal tubule).

2. Therapeutic Uses

Used strictly for patients requiring rapid or massive mobilization of fluids:

• Acute Pulmonary Edema: This is their major use.
• Congestive Heart Failure (CHF): When severe diminution of Extracellular Fluid (ECF) volume is required to minimize venous and pulmonary congestion.
• Cirrhosis of the liver complicated by ascites (fluid in the abdomen).
• Severe edema of Nephrotic Syndrome or Renal Failure.
• Severe Hypertension: Used when BP is uncontrolled by other diuretics. (Note: their short half-life makes them less useful than thiazides for standard, mild hypertension).
• Hypercalcemia: Because they force calcium out in the urine.

3. Adverse Drug Reactions (ADRs)

Because they are so powerful, their side effects are severe derivations of electrolyte loss:

• Dehydration (Hypovolemia): Leading to severe hypotension and fainting.
• Uric Acid Effects:
  • Acute Admin: Hypouricemia (increases uric acid excretion).
  • Chronic Admin: Hyperuricemia and Gout. Dehydration causes the proximal tubule to hyper-absorb. Also, the diuretic competes with uric acid for the organic secretory pump in the proximal tubule. The diuretic wins, leaving uric acid trapped in the blood, settling into joints to cause painful Gout.
• Metabolic: Hypercholesterolemia, hypertriglyceridemia, increased LDL.
• Ototoxicity: Dose-related tinnitus (ringing), hearing impairment, deafness, vertigo, and a sense of fullness in the ears. The inner ear uses similar electrolyte transport mechanisms, which the drug accidentally blocks.
• Others: Rashes, photosensitivity, paresthesias, bone marrow depression, and GI disturbances.

4. Drug Interactions

• Digitalis: Hypokalemia vastly potentiates digitalis toxicity (fatal arrhythmias).
• NSAIDs (Ibuprofen): Reduces the diuretic efficacy! NSAIDs block prostaglandin (PGE2) synthesis. Without PGE2, Na⁺ reabsorption is favored, fighting the diuretic.
• Aminoglycosides & Cisplatin: Highly enhances the risk of permanent ototoxicity and nephrotoxicity.
• Antiarrhythmics (Quinidine): A potentially lethal interaction. Quinidine prolongs the QT interval. Loop-induced hypokalemia wildly increases the risk of Torsades de pointes (a fatal polymorphic ventricular tachycardia) triggered by early after-depolarizations.
• Lithium: Causes Lithium toxicity due to decreased renal elimination.
• Thiazides: Synergism! Combining them leads to profound, dangerous diuresis.
• Corticosteroids / Amphotericin B: Intensify the dangerous loss of potassium.

---

V. Thiazide Diuretics and Related Drugs

Examples: Hydrochlorothiazide (Prototype), Bendroflumethiazide, Chlorothiazide. Related: Metolazone, Chlorthalidone, Indapamide.

These are the most commonly used diuretics globally. They are weak diuretics but also possess mild intrinsic vasodilator properties, making them exceptional for blood pressure control.

• Site & Mechanism of Action: They act on the Distal Convoluted Tubule (DCT). They physically block the Na⁺/Cl^- co-transporter, preventing sodium and chloride reabsorption, forcing water to follow it into the urine.
• Kidney Dependency: They are significantly less powerful than loop diuretics. Crucially, their action heavily depends on adequate kidney function; they are ineffective when GFR is low (unlike loop diuretics, which still work in renal failure).

1. Pharmacokinetics

• Taken orally, usually once a day.
• Onset is 2 hours after administration. Peaks at 4-6 hours and persists for up to 12 hours.

2. Therapeutic Uses

• Hypertension: The absolute preferred first-line agent in uncomplicated hypertension. They are better tolerated than loops and clinical trials prove they reduce the risk of stroke and heart attacks.
• Mild/Moderate Edema: Used in mild CHF (though loops are preferred for severe cases).
• Severe Resistant Edema: Metolazone is famous for being used synergistically with loop diuretics to break stubborn edema.
• Idiopathic Hypercalciuria: Because they pull calcium out of the urine, they are given to prevent recurrent calcium kidney stone formation.
• Nephrogenic Diabetes Insipidus: Paradoxically, they reduce urine volume by up to 50% in this disease, though the exact mechanism remains mysterious.

3. Adverse Drug Reactions (ADRs)

Many ADRs are identical to Loop diuretics, but with a few key differences:

• Electrolytes: Hypokalemia, Hyponatremia, Hypochloremia, Hypomagnesemia. Metabolic alkalosis. Unlike Loops, they cause Hypercalcemia.
• Metabolic: Hyperuricemia (chronic use = Gout), Hyperglycemia (in diabetics), Hypercholesterolemia, hypertriglyceridemia, increased LDL.
• Azotemia: Toxic buildup of nitrogenous waste in patients with pre-existing renal disease.
• Male Impotence: The reduced blood volume and arterial pressure cause massive activation of the RAAS system. This leads to systemic vasoconstriction, severely impacting erectile function.
• Idiosyncratic: Rashes, and blood dyscrasias like thrombocytopenia (low platelets).

4. Interactions

Similar to Loops: Hypokalemia potentiates Digitalis toxicity and quinidine-induced Torsades de pointes. NSAIDs reduce their efficacy. Bile acid sequestrants reduce their absorption from the gut. Corticosteroids worsen hypokalemia. They diminish the effect of insulin/sulfonylureas. They induce Lithium toxicity.

---

VI. Potassium-Sparing Diuretics

These are very weak diuretics. They are rarely used alone. Their entire purpose is to be used in conjunction with loop and thiazide diuretics. They provide two useful responses: a modest increase in urine, and a substantial decrease in K⁺ excretion, acting as a shield against the fatal hypokalemia caused by the stronger drugs.

They are divided into two subcategories based on exactly how they work in the collecting duct.

Uses & Adverse Effects of Potassium-Sparing Diuretics

• Uses (Spironolactone): Added to K⁺-losing diuretics to prevent dangerous hypokalemia (especially in patients on digoxin or amiodarone). It is the diuretic of choice for hepatic cirrhosis and nephrotic syndrome. Added to heart failure therapy to prevent fibrotic remodeling of the heart. Used to treat Primary (Conn's Syndrome) and Secondary hyperaldosteronism.
• Dangerous ADR: Hyperkalemia. Retaining too much potassium is just as fatal as losing it. This can stop the heart.
• Endocrine ADRs (Spironolactone only): Because spironolactone is a steroid, it accidentally acts on progesterone and androgen receptors throughout the body. This results in Gynecomastia (male breast tissue growth), menstrual disorders, and testicular atrophy.
• Contraindications: Absolutely contraindicated in patients who already have hyperkalemia, or patients at high risk (renal failure, patients on ACE inhibitors, or taking K⁺ supplements).

---

VII. Osmotic Diuretics

Examples: Mannitol (Osmitrol, mostly IV), Urea (IV), Glycerin (oral), Isosorbide (oral).

These drugs act completely differently from the others. Mannitol is simply a sugar molecule. It acts like a molecular "sponge" moving through the blood and kidneys.

• Mechanism of Action: Mannitol is freely filtered in the glomerulus. It undergoes minimal reabsorption, is not metabolized, and is pharmacologically inert. Once inside the lumen of the nephron, it creates a massive osmotic force. It literally holds onto water, inhibiting passive reabsorption, thereby wildly increasing urine flow. It has no significant direct effect on the excretion of K⁺ or other electrolytes.
• Kinetics: Very poorly absorbed by the GIT. If you drink it, it stays in the gut and pulls water into the intestines, causing osmotic diarrhea. Therefore, for systemic effects on the kidneys or brain, it must be given IV. Distributes entirely into extracellular water. Diuresis begins in 30-60 mins and lasts 6 hours.

Therapeutic Uses & Severe Warnings

• Uses: Prophylaxis of acute renal failure (to forcefully maintain urine flow and wash out debris).
  Brain & Eye: In the brain, its hyperosmotic presence in the blood draws water out of the swollen brain tissue, reducing Intracranial Pressure (ICP). It works the exact same way in the eye, pulling out intraocular fluid to reduce Intraocular Pressure (IOP).
• Adverse Effects: Transient expansion of ECF volume. Before mannitol gets filtered by the kidneys, it sits in the blood and pulls water out of the body's tissues into the vascular system. This suddenly expands blood volume, carrying a massive risk of causing Left Ventricular Failure (Pulmonary Edema) in a weak heart.
• Also causes dilutional hyponatremia, leading to headache, nausea, and vomiting.

---

VIII. Carbonic Anhydrase Inhibitors (CAIs)

Examples: Acetazolamide (Diamox, Glaumox), Dichlorphenamide (Daranide), Methazolamide (Glauctabs).

These are very weak diuretics and are rarely used to mobilize fluid. Their value lies in their ability to manipulate body pH and specific fluid pressures.

Therapeutic Uses

• Glaucoma: Carbonic anhydrase is present in extrarenal tissues. In the ciliary processes of the eye, it mediates the formation of large amounts of bicarbonate into aqueous humor. Inhibiting it drops the formation of eye fluid, reducing IOP. Used in Open-angle and secondary/pre-operative acute angle-closure glaucoma.
• Acute Altitude Sickness: In the erythrocytes, CAIs interfere with CO₂ transport. This effectively increases CO₂ in peripheral tissues and drops it in expired gas. This mild induced acidosis stimulates the brain to breathe deeper and faster, treating altitude sickness. (More effective if given prophylactically).
• Infantile Epilepsy: Acetazolamide creates a mild metabolic acidosis which has a direct anticonvulsant action in the CNS (though rapid tolerance limits usefulness).
• Correcting Alkalosis: Specifically metabolic alkalosis caused by severe diuretic-induced H⁺ excretion.

---

IX. Summary: General Indications for Diuretics